Subscribe - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 22 March 2018

Advanced search - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder


Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links

Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS


Latest impact factors for gastroenterology and hepatology journals

Interesting changes have been revealed from the latest gastroenterology and hepatology journal impact factors, for the year 2000.

News image


Gastroenterology is still the journal with the greatest impact factor, followed by Hepatology.

However, now in third place is Seminars in Liver Disease. This journal was 7th in 1999. Gut has therefore been displaced into 4th place.

Alimentary Pharmacology & Therapeutics is another improver - it has moved up to 6th place, from last year's position of 8th.

The impact factors are published by ISI. Their definition of an impact factor is "a measure of the frequency with which the 'average article' in a journal has been cited in a particular year or period."

The annual journal citation report impact factor is a ratio between citations and recent citable items published. Thus, the impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.

Journals with greatest impact:
1 Gastroenterology
2 Hepatology
3 Semin Liver Dis
4 Gut
5 J Hepatol
6 Aliment Pharmacol Ther

ISI explain that, "The impact factor is useful in clarifying the significance of absolute (or total) citation frequencies. It eliminates some of the bias of such counts, which favor large journals over small ones, or frequently issued journals over less frequently issued ones, and of older journals over newer ones. Particularly in the latter case such journals have a larger citable body of literature than smaller or younger journals.

"All things being equal, the larger the number of previously published articles, the more often a journal will be cited."

Here is the "Top Forty Four" of the impact factors for 2000:

Journal    Impact factor
Gastroenterology    12.246
Hepatology    7.304
Semin Liver Dis    6.012
Gut    5.386
J Hepatol    3.761
Aliment Pharmacol Ther    3.489
Am J Physiol-Gastr L    3.115
Am J Gastroenterol    2.834
Gastrointest Endosc    2.820
Helicobacter    2.639
J Viral Hepat    2.157
Liver Transplant    2.130
Neurogastroenterol Motil    2.081
Scand J Gastroenterol    1.842
Endoscopy    1.817
Hepatol Res    1.808
Inflamm Bowel Dis    1.791
Digestion    1.780
Gastroenterol Clin North Am    1.774
Liver    1.739
Bailliere Clin Gastr    1.733
Int J Colorectal Dis    1.707
Dis Colon Rectum    1.690
Can J Gastroenterol    1.645
J Pediatr Gastroenterol Nutr    1.580
Dig Dis Sci    1.498
Ital J Gastroenterol    1.289
Eur J Gastroenterol Hepatol    1.142
J Clin Gastroenterol    1.127
J Gastroenterol Hepatol    1.116
World J Gastroenterol    0.993
J Gastroenterol    0.990
Gastroen Clin Biol    0.927
Hepato-Gastroenterol    0.905
Z Gatsroenterol    0.887
Abdom Imaging    0.886
Dig Surg    0.810
Dig Dis    0.744
Acta Gastro-Ent Belg    0.605
Curr Opin Gastroen    0.577
Rev Esp Enferm Dig    0.384
J Diarrhoel Dis Res    0.379
Chir Gastroenterol    0.078
Best Pract Res Cl Ga    0.067

03 September 2001

Go to top of page Email this page Email this page to a colleague

 22 March 2018 
Mechanisms of action in patients with IBS
 22 March 2018 
H. pyloris and gastric cancer
 22 March 2018 
Pancreatitis after IBS treatment 
 21 March 2018 
Blood test differentiates celiac disease
 21 March 2018 
Patient characteristics and colonoscopy preparation
 21 March 2018 
Panel markers for early detection of colon cancer

 20 March 2018 
Therapeutic strategies for IBD
 20 March 2018 
Acute lower GI bleeding in the UK
 20 March 2018 
Bloody vs coffee-grounds hematemesis
 19 March 2018 
Genetics in young individuals with colorectal cancer
 19 March 2018 
Small intestinal histology in celiac disease
 19 March 2018 
Bacteriophage transfer during fecal microbiota transplant in C. difficile
 16 March 2018 
H. pylori infection and hyperemesis gravidarum
 16 March 2018 
Low-dose aspirin use in esophagogastric cancer
 16 March 2018 
Microbiome of professional athletes
 15 March 2018 
NAFLD prevalence in the USA
 15 March 2018 
Predictors of postoperative infection in Crohn's
 15 March 2018 
Decision aid used by IBD patients
 14 March 2018 
Treatment should account for the zonality of steatosis
 14 March 2018 
PPI treatment in high risk patients for pyogenic liver abscess
 14 March 2018 
NAFLD treatment in Asia Pacific region
 13 March 2018 
Physician perception of IBD trial results
 13 March 2018 
Psychiatric comorbidities and frequent healthcare encounters mediate some of the opioid use risk
 13 March 2018 
Increasing mortality from gallbladder cancer
 12 March 2018 
Standardized protocol for PPI-refractory GERD
 12 March 2018 
Predicting remission with vedolizumab in ulcerative colitis
 12 March 2018 
Scribes improve outcomes in IBD clinics
 09 March 2018 
Tenofovir and perinatal transmission of Hep B
 09 March 2018 
Few adverse effects have been reported in peppermint oil trials
 09 March 2018 
Contact precautions for endemic MRSA and VRE
 08 March 2018 
New nucleotide analogue for chronic Hep B
 08 March 2018 
Amitriptyline in functional dyspepsia
 08 March 2018 
Combination treatment beneficial for IBD
 07 March 2018 
Rebleeding in upper GI bleeds
 07 March 2018 
Vedolizumab in preventing postoperative Crohn's
 06 March 2018 
Transition for young adults with IBD
 06 March 2018 
Health conditions and some medications predict inadequate bowel preparation
 06 March 2018 
Mortality in infliximab-treated vs other-treatments-only groups for Crohn's
 05 March 2018 
Novel insights into IBD
 05 March 2018 
NALFD in liver transplant
 05 March 2018 
Adult ulcerative colitis
 02 March 2018 
Psychosocial factors in IBD
 02 March 2018 
Antiviral therapy to reduce extrahepatic manifestations 
 01 March 2018 
Google can affect food purchases for gluten-free diets
 01 March 2018 
Red meat associated with diverticulitis risk in men
 28 February 2018 
Global GERD prevalence
 28 February 2018 
Anti-inflammatory drug-induced liver injuries
 28 February 2018 
Disease severity in microscopic colitis
 27 February 2018 
Barrett's esophagus and esophageal cancer
 27 February 2018 
Hospice care for primary liver cancer
 27 February 2018 
Transplant waiting lists for autoimmune liver disease
 26 February 2018 
Hepatocellular carcinoma risk in Hep B
 26 February 2018 
Metabolic effects of new therapies of NASH
 26 February 2018 
Novel targets for hepatocellular carcinoma
 23 February 2018 
Patients on antithrombotic agents undergoing emergency and elective endoscopy
 23 February 2018 
 23 February 2018 
Heavy metals on a gluten-free diet
 22 February 2018 
Outcomes with Crohn’s after infliximab withdrawal
 22 February 2018 
Elderly onset of IBD

 22 February 2018 
Autophagy enhancers

Blackwell Publishing is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and and contributors
Privacy Statement
About Us